These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22407747)

  • 1. New oral anticoagulants: a view from the laboratory.
    Weitz JI
    Am J Hematol; 2012 May; 87 Suppl 1():S133-6. PubMed ID: 22407747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa.
    Bauer KA
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():12-9. PubMed ID: 21781237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K.
    Whitlock RP; Crowther MA; Warkentin TE; Blackall MH; Farrokhyar F; Teoh KH
    Ann Thorac Surg; 2007 Jul; 84(1):103-8. PubMed ID: 17588394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives to warfarin--the next generation of anticoagulants.
    Kanagasabapathy P; Chowdary P; Gatt A
    Cardiovasc Ther; 2011 Dec; 29(6):e80-8. PubMed ID: 20626755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.
    De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L
    Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of oral anticoagulants: implications for therapy.
    Shetty HG; Woods F; Routledge PA
    J Heart Valve Dis; 1993 Jan; 2(1):53-62. PubMed ID: 8269110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulants and the metabolism of vitamin K-dependent clotting factors.
    Gonmori H; Takeuchi T; Tanaka H; Kobayashi N; Maekawa T
    Nihon Ketsueki Gakkai Zasshi; 1982 Jul; 45(4):817-29. PubMed ID: 7136469
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of major bleedings during anticoagulant treatment with the oral direct thrombin inhibitor ximelagatran or warfarin.
    Fernlöf G; Sjöström BM; Lindell KM; Wall UE
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):667-74. PubMed ID: 19741508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oral anticoagulants.
    Khoo CW; Tay KH; Shantsila E; Lip GY
    Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New anticoagulants & clinical trials.
    Haideri N; Patel H
    Mo Med; 2009; 106(1):60-4. PubMed ID: 19245126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant drugs: what is new?
    Kei A; Florentin M; Elisaf M; Liberopoulos E
    Int Angiol; 2011 Aug; 30(4):299-320. PubMed ID: 21747349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will warfarin ever be replaced?
    Ruff CT; Braunwald E
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):210-9. PubMed ID: 20484119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K and the oral anticoagulant drugs.
    O'Reilly RA
    Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification.
    Cabral KP; Ansell J; Hylek EM
    J Thromb Haemost; 2011 Mar; 9(3):441-9. PubMed ID: 21176102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.